DeepMind
-
healthIsomorphic Labs Raises $2.1B to Scale AI Drug Discovery
Google-backed Isomorphic Labs secures $2.1 billion in Series C funding to scale its AI-powered drug design engine and accelerate clinical trials.
-
techDeepMind CEO Warns: China's Open-Source AI Surpassing Google
Demis Hassabis says Chinese models now lead global benchmarks, challenging U.S. dominance in AI.
-
techDemis Hassabis: AGI by 2030 Possible, Model Distillation Key to AI Efficiency
Google DeepMind CEO Demis Hassabis discusses the potential for Artificial General Intelligence by 2030, advancements in model distillation, and lessons learned from AlphaGo.
-
techDeepMind Unveils Gemini Robotics-ER 1.6 for Enhanced Physical AI
Google DeepMind introduces Gemini Robotics-ER 1.6, a new AI model designed for advanced spatial reasoning and autonomy in robots, impacting robotics, manufacturing, and logistics.
-
techAGI Within 5 Years? DeepMind CEO Demis Hassabis on AI's Future
DeepMind CEO Demis Hassabis discusses the rapid pace of AI development, the potential for AGI within five years, and the critical role of key research labs.
-
techAI Fails at Simple Math-Based Games
DeepMind's AI excels at chess and Go but struggles with Nim, revealing a critical flaw in self-training methods when symbolic reasoning is required.
-
techAI Startup Ineffable Intelligence Seeks $1 Billion Funding
Former DeepMind scientist David Silver's new AI venture, Ineffable Intelligence, is reportedly in talks to raise $1 billion, signaling significant investor confidence in its future technology.